 Rebecca Keith
Concepts (104)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Arthritis, Experimental | 2 | 2013 | 126 | 0.850 |
Why?
| | Arthritis, Rheumatoid | 3 | 2017 | 923 | 0.630 |
Why?
| | Pulmonary Fibrosis | 3 | 2011 | 314 | 0.540 |
Why?
| | Lung Diseases, Interstitial | 2 | 2017 | 390 | 0.450 |
Why?
| | Testosterone | 1 | 2013 | 321 | 0.400 |
Why?
| | Bleomycin | 4 | 2018 | 205 | 0.400 |
Why?
| | Alveolitis, Extrinsic Allergic | 2 | 2019 | 78 | 0.360 |
Why?
| | Acute Lung Injury | 1 | 2011 | 320 | 0.350 |
Why?
| | Idiopathic Pulmonary Fibrosis | 3 | 2018 | 348 | 0.340 |
Why?
| | Autoimmunity | 1 | 2013 | 754 | 0.330 |
Why?
| | Lung Diseases | 1 | 2013 | 725 | 0.310 |
Why?
| | Lung | 5 | 2014 | 3558 | 0.240 |
Why?
| | Disease Models, Animal | 2 | 2014 | 3828 | 0.240 |
Why?
| | Lactic Acid | 1 | 2022 | 296 | 0.200 |
Why?
| | Protein Tyrosine Phosphatase, Non-Receptor Type 13 | 1 | 2018 | 6 | 0.190 |
Why?
| | fas Receptor | 3 | 2018 | 99 | 0.180 |
Why?
| | Fatty Acids | 1 | 2022 | 429 | 0.180 |
Why?
| | Lung Compliance | 3 | 2014 | 53 | 0.180 |
Why?
| | Myofibroblasts | 1 | 2018 | 118 | 0.160 |
Why?
| | Cause of Death | 1 | 2019 | 390 | 0.160 |
Why?
| | Mortality | 1 | 2019 | 326 | 0.160 |
Why?
| | Apoptosis | 2 | 2018 | 2607 | 0.140 |
Why?
| | Mice | 7 | 2018 | 15432 | 0.130 |
Why?
| | Collagen | 2 | 2011 | 432 | 0.120 |
Why?
| | Bronchoalveolar Lavage Fluid | 2 | 2011 | 624 | 0.110 |
Why?
| | Mucin-5B | 1 | 2013 | 151 | 0.110 |
Why?
| | Respiratory Mucosa | 1 | 2013 | 234 | 0.110 |
Why?
| | Mice, Mutant Strains | 1 | 2011 | 308 | 0.110 |
Why?
| | Sex Characteristics | 2 | 2013 | 686 | 0.110 |
Why?
| | Macrophages, Alveolar | 1 | 2014 | 350 | 0.100 |
Why?
| | Exercise | 1 | 2022 | 1755 | 0.100 |
Why?
| | Smoke | 1 | 2011 | 132 | 0.100 |
Why?
| | Mice, Inbred BALB C | 1 | 2011 | 1315 | 0.090 |
Why?
| | Lung Injury | 1 | 2011 | 221 | 0.090 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2014 | 1242 | 0.090 |
Why?
| | Animals | 7 | 2018 | 34690 | 0.090 |
Why?
| | Up-Regulation | 1 | 2011 | 942 | 0.080 |
Why?
| | Tomography, X-Ray Computed | 1 | 2017 | 2379 | 0.080 |
Why?
| | Fibroblasts | 1 | 2011 | 864 | 0.080 |
Why?
| | Female | 8 | 2022 | 63070 | 0.070 |
Why?
| | Male | 9 | 2022 | 60818 | 0.070 |
Why?
| | Mice, Knockout | 3 | 2018 | 2835 | 0.060 |
Why?
| | Survival Analysis | 2 | 2017 | 1410 | 0.060 |
Why?
| | Fever | 1 | 2022 | 303 | 0.050 |
Why?
| | Occupations | 1 | 2019 | 41 | 0.050 |
Why?
| | Oxygen Consumption | 1 | 2022 | 664 | 0.050 |
Why?
| | Drug Resistance, Microbial | 1 | 2018 | 63 | 0.050 |
Why?
| | Mice, Inbred C57BL | 3 | 2014 | 5137 | 0.050 |
Why?
| | Tissue Culture Techniques | 1 | 2018 | 72 | 0.040 |
Why?
| | Oxidation-Reduction | 1 | 2022 | 979 | 0.040 |
Why?
| | Mice, Transgenic | 2 | 2014 | 2101 | 0.040 |
Why?
| | Biopsy, Needle | 1 | 2018 | 194 | 0.040 |
Why?
| | Lipid Metabolism | 1 | 2022 | 526 | 0.040 |
Why?
| | Pulmonary Diffusing Capacity | 1 | 2017 | 55 | 0.040 |
Why?
| | Idiopathic Interstitial Pneumonias | 1 | 2017 | 36 | 0.040 |
Why?
| | Referral and Consultation | 1 | 2022 | 648 | 0.040 |
Why?
| | Forecasting | 1 | 2019 | 389 | 0.040 |
Why?
| | Reference Values | 1 | 2018 | 852 | 0.040 |
Why?
| | Vital Capacity | 1 | 2017 | 249 | 0.040 |
Why?
| | Rheumatoid Factor | 1 | 2017 | 142 | 0.040 |
Why?
| | RNA, Small Interfering | 1 | 2018 | 599 | 0.040 |
Why?
| | Retrospective Studies | 2 | 2022 | 11642 | 0.040 |
Why?
| | Down-Regulation | 1 | 2018 | 663 | 0.040 |
Why?
| | Chronic Disease | 1 | 2022 | 1649 | 0.040 |
Why?
| | Humans | 7 | 2022 | 114578 | 0.040 |
Why?
| | Receptor, Macrophage Colony-Stimulating Factor | 1 | 2014 | 7 | 0.030 |
Why?
| | Hydroxyproline | 1 | 2014 | 24 | 0.030 |
Why?
| | Tacrolimus Binding Proteins | 1 | 2014 | 16 | 0.030 |
Why?
| | Middle Aged | 3 | 2022 | 28854 | 0.030 |
Why?
| | Cells, Cultured | 2 | 2014 | 4281 | 0.030 |
Why?
| | Immunohistochemistry | 1 | 2018 | 1783 | 0.030 |
Why?
| | Mucin 5AC | 1 | 2013 | 44 | 0.030 |
Why?
| | Remission Induction | 1 | 2014 | 267 | 0.030 |
Why?
| | Ear, Middle | 1 | 2013 | 81 | 0.030 |
Why?
| | United States | 2 | 2019 | 12551 | 0.030 |
Why?
| | Cilia | 1 | 2013 | 144 | 0.030 |
Why?
| | Bacterial Infections | 1 | 2013 | 214 | 0.030 |
Why?
| | Phagocytosis | 1 | 2013 | 377 | 0.030 |
Why?
| | Chemokine CXCL1 | 1 | 2011 | 70 | 0.030 |
Why?
| | Fas Ligand Protein | 1 | 2011 | 60 | 0.030 |
Why?
| | Cell Line, Transformed | 1 | 2011 | 166 | 0.030 |
Why?
| | Trauma Severity Indices | 1 | 2011 | 141 | 0.030 |
Why?
| | Case-Control Studies | 1 | 2018 | 3249 | 0.030 |
Why?
| | Staphylococcus aureus | 1 | 2013 | 379 | 0.020 |
Why?
| | Recovery of Function | 1 | 2014 | 615 | 0.020 |
Why?
| | Adult | 2 | 2022 | 32077 | 0.020 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2011 | 884 | 0.020 |
Why?
| | Smoking | 1 | 2017 | 1584 | 0.020 |
Why?
| | Prognosis | 1 | 2017 | 3546 | 0.020 |
Why?
| | Transforming Growth Factor beta | 1 | 2011 | 462 | 0.020 |
Why?
| | Macrophages | 1 | 2013 | 1315 | 0.020 |
Why?
| | Survival Rate | 1 | 2011 | 1859 | 0.020 |
Why?
| | Models, Biological | 1 | 2013 | 1807 | 0.020 |
Why?
| | Sex Factors | 1 | 2011 | 1971 | 0.020 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2013 | 1209 | 0.020 |
Why?
| | Cell Line | 1 | 2011 | 2924 | 0.020 |
Why?
| | Gene Expression Profiling | 1 | 2011 | 1561 | 0.020 |
Why?
| | Longitudinal Studies | 1 | 2011 | 2666 | 0.020 |
Why?
| | Age Factors | 1 | 2011 | 3280 | 0.020 |
Why?
| | Inflammation | 1 | 2013 | 2442 | 0.010 |
Why?
| | Time Factors | 1 | 2014 | 7029 | 0.010 |
Why?
| | Asthma | 1 | 2013 | 2039 | 0.010 |
Why?
| | Prospective Studies | 1 | 2011 | 6288 | 0.010 |
Why?
| | Aged | 1 | 2017 | 20219 | 0.010 |
Why?
|
|
Keith's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|